Pediatric timing of epinephrine doses: A systematic review.

Children Good neurological outcome Hospital discharge Infant ROSC Survival

Journal

Resuscitation
ISSN: 1873-1570
Titre abrégé: Resuscitation
Pays: Ireland
ID NLM: 0332173

Informations de publication

Date de publication:
03 2021
Historique:
received: 12 07 2020
revised: 23 12 2020
accepted: 11 01 2021
pubmed: 3 2 2021
medline: 22 6 2021
entrez: 2 2 2021
Statut: ppublish

Résumé

To evaluate the optimal timing and doses of epinephrine for Infants and children suffering in-hospital or out-of-hospital cardiac arrest. We searched Medline, EMBASE, and Cochrane Controlled Register of Trials (CENTRAL) for human randomized clinical trials and observational studies including comparative cohorts. Two investigators reviewed relevance of studies, extracted the data, conducted meta-analyses and assessed the risk of bias using the GRADE and CLARITY frameworks. Authors of the eligible studies were contacted to obtain additional data. Critically important outcomes included return of spontaneous circulation, survival to hospital discharge and survival with good neurological outcome. We identified 7 observational studies suitable for meta-analysis and no randomized clinical trials. The overall certainty of evidence was very low. For the critically important outcomes, the earlier administration of epinephrine was favorable for both in-hospital and out-of-hospital cardiac arrest. Because of a limited number of eligible studies and the presence of severe confounding factors, we could not determine the optimal interval of epinephrine administration. Earlier administration of the first epinephrine dose could be more favorable in non-shockable pediatric cardiac arrest. The optimal interval for epinephrine administration remains unclear.

Identifiants

pubmed: 33529645
pii: S0300-9572(21)00023-X
doi: 10.1016/j.resuscitation.2021.01.015
pii:
doi:

Substances chimiques

Epinephrine YKH834O4BH

Types de publication

Journal Article Meta-Analysis Research Support, Non-U.S. Gov't Review Systematic Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

106-117

Investigateurs

Anne-Marie Guerguerian (AM)
David Kloeck (D)
Vinay Nadkarni (V)
Kee-Chong Ng (KC)
Gabrielle Nuthall (G)
Yong-Kwang Gene Ong (YG)
Amelia Reis (A)
Steve Schexnayder (S)
Janice Tijssen (J)
Patrick Van de Voorde (P)
Mary Fran Hazinski (MF)
Peter A Meaney (PA)

Informations de copyright

Copyright © 2021 Elsevier B.V. All rights reserved.

Auteurs

Shinichiro Ohshimo (S)

Department of Emergency and Critical Care Medicine, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan. Electronic address: ohshimos@hiroshima-u.ac.jp.

Chih-Hung Wang (CH)

Department of Emergency Medicine, College of Medicine, National Taiwan University, Taipei, Taiwan.

Thomaz Bittencourt Couto (TB)

Hospital Israelita Albert Einstein and University of Sao Paulo, Sao Paulo, Brazil.

Robert Bingham (R)

Great Ormond Street Hospital, London, UK.

Yee Hui Mok (YH)

Duke-NUS Medical School, Singapore, Singapore.

Monica Kleinman (M)

Department of Anesthesiology, Critical Care and Pain Medicine, Boston Children's Hospital, Boston, MA, USA.

Richard Aickin (R)

Department of Paediatrics and Child Health, University of Auckland, New Zealand.

Carolyn Ziegler (C)

Health Sciences Library, St. Michael's Hospital, Toronto, Canada.

Allan DeCaen (A)

University of Alberta, Pediatric Critical Care Medicine, Edmonton, Canada.

Dianne L Atkins (DL)

Stead Family Department of Pediatrics, Carver College of Medicine, University of Iowa, IA, USA.

Ian Maconochie (I)

Paediatric Emergency Department, Imperial College Healthcare NHS Trust, London, United Kingdom.

Yacov Rabi (Y)

Department of Pediatrics, University of Calgary, Calgary, Alberta, Canada.

Laurie Morrison (L)

Department of Medicine, Division of Emergency Medicine, University of Toronto, Toronto, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH